Cell-Based Regeneration and Treatment of Liver Diseases

The liver, the largest vital organ, assumes the role of orchestrating a diverse array of metabolic functions. These encompass the delicate equilibrium of carbohydrates, lipids, and proteins. Furthermore, the liver takes on a pivotal role as the primary agent of detoxification, while simultaneously upholding a critical function in effective immune response. Despite significant strides in both surgical and pharmaceutical treatment modalities, liver-related disorders continue to occupy a prominent position among leading causes of mortality.
Renowned researchers from Austria shed light on the pivotal aspect of selecting the optimal therapeutic interventions. Their discourse extends to innovative technologies that hold the potential to provide an edge in implementing these groundbreaking treatment strategies. The regenerative potential of acute liver injury or disease predominantly hinges on the ability of hepatocytes to re-enter the cell cycle. However, in cases of chronic liver injury, a majority of hepatocytes experience senescence, necessitating the exploration of alternative therapeutic pathways.
The exploration of hepatocyte and biliary epithelial cell (BEC) transplantation has traversed an extensive spectrum of diseases, yielding the most promising outcomes in the realm of metabolic disorders. These transplantation approaches can be categorized into two distinct types: autologous and allogeneic. The first one employs patient's own cells, whereas the second one involves the acquisition of donor cells that are subsequently transplanted into the recipient's system.